$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Week 10/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD in week 10/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 0.00 | 80,798 | 0 | 80,798 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 13,930 | 0 | 27,861 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 10.57 | 13,930 | 147,186 | 2,974 | 16.9 K to 3 K (-82.41 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 13,930 | 0 | 16,904 | 3 K to 16.9 K (+468.39 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | A | 0.00 | 285,171 | 0 | 285,171 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | M | 0.00 | 59,701 | 0 | 119,403 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Buy | M | 0.00 | 59,701 | 0 | 860,582 | 800.9 K to 860.6 K (+7.45 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | A | 0.00 | 95,057 | 0 | 95,057 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 15,920 | 0 | 31,841 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 15,920 | 0 | 147,842 | 131.9 K to 147.8 K (+12.07 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 12,935 | 0 | 25,870 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 10.58 | 12,935 | 136,909 | 0 | 12.9 K to 0 (-100.00 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Grant | A | 0.00 | 12,935 | 0 | 12,935 | 0 to 12.9 K |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 85,551 | 0 | 85,551 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 95,057 | 0 | 95,057 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 18,905 | 0 | 37,811 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.57 | 9,515 | 100,536 | 73,454 | 83 K to 73.5 K (-11.47 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 18,905 | 0 | 82,969 | 64.1 K to 83 K (+29.51 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | A | 0.00 | 90,304 | 0 | 90,304 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 11,940 | 0 | 23,880 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 10.58 | 6,183 | 65,443 | 55,048 | 61.2 K to 55 K (-10.10 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 11,940 | 0 | 61,231 | 49.3 K to 61.2 K (+24.22 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | A | 0.00 | 99,809 | 0 | 99,809 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 13,930 | 0 | 27,861 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 10.57 | 6,012 | 63,523 | 77,976 | 84 K to 78 K (-7.16 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 13,930 | 0 | 83,988 | 70.1 K to 84 K (+19.88 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | A | 0.00 | 90,304 | 0 | 90,304 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 15,920 | 0 | 31,841 | |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 10.58 | 7,513 | 79,521 | 20,280 | 27.8 K to 20.3 K (-27.03 %) |
| Mar 08 2021 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 15,920 | 0 | 27,793 | 11.9 K to 27.8 K (+134.09 %) |